Skip to main content

Table 1 The clinical characteristics of the other 56 patients received allo-HSCT

From: Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation

Characteristics Total
Number 56
Patient age, median (range) age 31 (8–54)
Patient sex, male, n (%) 31 (55.0%)
Patient/donor HLA incompatibility  
Related matched 16
Related mis-matched 40
Diagnosis  
AML,n (%) 29
CML,n (%) 1
B-ALL,n (%) 24
MDS,n (%) 1
BAL,n (%) 1
Disease status  
High risk 29 (52.0%)
Standard risk 27 (48.0%)
Situation after allo-HSCT  
No relapse indication 42
MRD+ 7
Haematological relapse 5
Extramedullary relapse 2
  1. AML, acute myeloid leukemia; B-ALL, B cell acute lymphoblastic leukemia; CML, chronic myeloid leukemia; MDS, Myelodysplastic syndrome; BAL, biphenotypic acute leukemia.